Daring to question deeply held beliefs and dreaming big can pave the way for extraordinary advancements – moonshots for those willing to break from conventional thinking and chart new paths into the unexplored territories of the human mind and brain.

Charting the course for moonshots
The next great leap in neurotechnology may not come from incremental improvements to existing approaches, but a paradigm shift that completely reframes how we think about the brain and mind. These strategies offer a framework to push the boundaries of possibility. Challenging ourselves to question assumptions, explore alternative explanations, and collaborate across disciplines in unprecedented ways can open up the possibility of new breakthroughs. These moonshots may revolutionize our understanding of the brain, leading to transformative treatments for a range of neurological and psychiatric conditions.
About the authors: Ruthi Aladjem is the chief product strategist at Corundum Neuroscience (CNS), a venture builder and fund dedicated to advancing neuroscience research and innovation. She brings over a decade of experience in product management, innovation and entrepreneurship, with a strong emphasis on user-centered approaches. At CNS, Ruthi is responsible for shaping product strategies that drive the development of life-changing neuroscience solutions. Prior to joining CNS, she served as an entrepreneur-in-residence at Joy Ventures. She also co-founded a startup in the educational technology sector. Ruthi holds a PhD in learning technologies from Tel Aviv University.

Sharena Rice is a research scientist at Sanmai Technologies, a public-benefit corporation developing a new medical device using focused ultrasound neuromodulation. She also serves as a contributing editor at Neurotech Reports, a leading source of news and in-depth analysis for the neurotechnology industry. Sharena is a grant advisor with the Foresight Institute, a think tank and public interest organization focused on transformative future technologies, and serves as US Advisory Board Member for Graspify AS, an open community for shared e-learning. She holds a PhD in Neuroscience from the University of Michigan.

Back to HCB News

Alzheimers/Neurology Homepage